
Introduction: Achilles tendon rupture and ankle fracture are each common in isolation, but their simultaneous occurrence in the same limb is rare. Because the two injuries share overlapping signs of pain, swelling, and functional limitation, one is often missed on initial evaluation, and a low threshold for combined clinical and sonographic or magnetic resonance imaging assessment is warranted in high-energy ankle trauma. Furthermore, while early functional weight-bearing is increasingly favored for isolated Achilles ruptures, its safety and implementation in combined injuries remain poorly defined. Case Report: A 34-year-old male sustained a closed Weber B bimalleolar ankle fracture and a complete Achilles tendon rupture during a high-energy snowboarding accident. Both injuries were identified preoperatively by clinical examination (palpable tendon defect, positive Thompson, and Matles tests) and ultrasonography. One week after injury, he underwent open reduction and internal fixation of the lateral malleolus with a lateral approach followed by repair of the Achilles using a Krackow-type suture-tape repair docked to the calcaneus with two SwiveLock anchors (Arthrex, Naples, FL). This was done through a separate posterior longitudinal incision. Intraoperative external rotation stress testing demonstrated no talar shift or medial malleolar fracture displacement, confirming stability and avoiding unnecessary medial fixation. At 1 week postoperatively, the patient was transitioned from a posterior splint to a boot with a heel wedge, and active range of motion was initiated. At 2 weeks, the patient was allowed to bear full weight in the boot with a heel wedge. Formal physical therapy began at 4 weeks. Conclusion: Concomitant Achilles tendon rupture and ankle fracture require a high index of suspicion for both injuries. Intraoperative stress testing after fibular fixation can guide the decision to forgo medial malleolar fixation. In addition, an early, protected rehabilitation protocol can be successfully implemented in patients with a combined Achilles rupture and malleolar fracture.
Introduction: Brodie’s abscess is a localized form of subacute osteomyelitis that usually presents as a well-defined lytic lesion with surrounding sclerosis and characteristic peripheral rim enhancement on magnetic resonance imaging (MRI). However, these imaging features are not specific and may also be seen in malignant bone lesions, creating a significant diagnostic challenge. The coexistence of infection and malignancy within the same lesion is extremely uncommon and can further complicate diagnosis. We report a rare case of metastatic esophageal squamous cell carcinoma (ESCC) involving the femoral head that clinically and radiologically mimicked Brodie’s abscess in the presence of concurrent methicillin-resistant Staphylococcus aureus (MRSA) infection. Case Report: A 53-year-old man with a long history of smoking presented with progressively worsening pain in the right groin and difficulty walking for 2 months. Laboratory investigations showed elevated inflammatory markers, and MRI demonstrated a rim-enhancing lesion in the femoral head with surrounding marrow edema, raising a strong suspicion of Brodie’s abscess. The patient underwent core decompression, during which friable grey-white tissue was encountered instead of the expected purulent material. Intraoperative cultures grew MRSA, initially supporting the diagnosis of subacute osteomyelitis. However, histopathological examination revealed metastatic squamous cell carcinoma. Further evaluation with upper gastrointestinal endoscopy confirmed a moderately differentiated squamous cell carcinoma of the mid-esophagus, establishing the femoral lesion as a metastatic deposit with superimposed MRSA infection. Conclusion: This case highlights the importance of maintaining a broad differential diagnosis when evaluating atypical bone lesions. Imaging findings and positive microbiological cultures alone may be misleading, particularly in patients with risk factors for malignancy. Histopathological examination remains the definitive diagnostic tool and should be obtained whenever there is diagnostic uncertainty, as early tissue diagnosis is essential for timely and appropriate management.
Introduction: Carpal tunnel syndrome (CTS) is the most common compressive neuropathy of the upper extremity, typically affecting middle-aged and elderly individuals. Occurrence in adolescents or young adults without identifiable systemic risk factors is uncommon and often indicates an underlying structural cause. Anatomical variations, such as anomalous muscle bellies or median nerve abnormalities can reduce the space within the carpal tunnel and lead to symptomatic nerve compression. Case Series: We present a series of four young patients aged 15–27 years who presented with symptoms suggestive of CTS without conventional risk factors. All patients demonstrated positive clinical provocative tests and electrophysiological evidence of median nerve compression. Imaging, where performed, suggested anatomical abnormalities within the carpal tunnel. Surgical exploration identified aberrant muscle bellies associated with median nerve compression; bifid median nerve and persistent median artery were also identified among the reported anatomical findings. All patients underwent open carpal tunnel release, with management of the aberrant muscle determined intraoperatively. Post-operative recovery was clinically favorable during the available short-term follow-up. Conclusion: Anatomical variations, such as aberrant muscle bellies and median nerve variants should be considered in young patients presenting with CTS symptoms, particularly when conventional risk factors are absent. In selected patients, imaging and careful intraoperative assessment may help identify structural contributors and guide individualized surgical management. Given the small case series and lack of a comparator, these observations should be considered hypothesis-generating rather than definitive.
Introduction: Obesity is an important modifiable risk factor for knee osteoarthritis, contributing to pain, functional limitation, and systemic inflammation. Semaglutide may provide benefits beyond weight reduction, but its effects on clinical and functional outcomes in obesity-associated knee osteoarthritis remain insufficiently characterized. Against this background, this study sought to evaluate the effects of 6-month semaglutide treatment on weight, knee pain, physical function, thigh skeletal muscle volume, and inflammatory markers in patients with obesity-associated knee osteoarthritis. Materials and Methods: This prospective, observational, single-arm study included 75 patients with obesity-associated knee osteoarthritis who received semaglutide and were followed for 6 months. Changes in weight, body mass index (BMI), knee pain assessed by the Visual Analogue Scale (VAS), physical function assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), thigh skeletal muscle volume, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were evaluated. Results: At the 6-month follow-up, body weight decreased from 101.23 ± 15.45 to 91.47 ± 9.67 kg (mean change −9.76 kg), while BMI decreased from 34.49 ± 3.67 to 31.89 ± 5.78 kg/m2 (−2.60 kg/ m2; both P < 0.001). VAS pain scores decreased from 6.90 ± 2.10 to 4.89 ± 0.73 (−2.01; P < 0.001), and WOMAC scores improved from 59.67 ± 6.47 to 44.60 ± 6.12 (−15.07; P < 0.001). Thigh skeletal muscle volume increased from 10.6 ± 2.3 to 11.1 ± 1.8 L (+0.50 L; P < 0.001). CRP decreased from 6.14 ± 0.73 to 3.91 ± 2.08 mg/L, while ESR decreased from 27.51 ± 3.32 to 19.64 ± 4.37 mm/h. Conclusion: 6 months of semaglutide treatment was associated with substantial weight loss and significant improvements in knee pain and physical function, accompanied by reductions in systemic inflammatory markers. These findings suggest potential benefits of semaglutide beyond weight reduction in obesity-associated knee osteoarthritis. Larger controlled studies with longer follow-up are warranted.
Introduction: A quadrupled semitendinosus (ST) graft diameter below 8.0 mm is associated with higher failure and revision rates after anterior cruciate ligament (ACL) reconstruction. Pre-operative identification of patients at risk of an undersized graft may facilitate planning for gracilis augmentation or alternative graft selection. Objective: To determine the diagnostic accuracy of a pre-operative Magnetic resonance imaging (MRI)-measured ST cross-sectional area (CSA) threshold of 18.5 mm² for predicting an intraoperative quadrupled graft diameter of at least 8.0 mm. Materials and Methods: Thirty-seven consecutive patients undergoing arthroscopic ACL reconstruction with a quadrupled ST autograft were enrolled in a prospective observational study. Pre-operative ST CSA was measured on axial MRI at the joint line by a single musculoskeletal radiologist blinded to intraoperative findings. Quadrupled ST graft diameter was measured intraoperatively with a standard graft-sizing block before any gracilis augmentation. A CSA cut-off of 18.5 mm², derived by receiver operating characteristic (ROC) analysis within this cohort, was evaluated against the 8.0 mm adequacy threshold using standard 2×2 diagnostic accuracy statistics. Results: Pre-operative CSA was strongly correlated with graft diameter (Spearman’s ρ = 0.948, P < 0.001). At the 18.5 mm² cut-off (adequate graft as the target condition), sensitivity was 100% (95% confidence interval [CI] 85.75–100%), specificity 84.62% (95% CI 54.55–98.08%), positive predictive value 92.31% (95% CI 77.03–97.72%), negative predictive value 100% (95% CI 71.51–100%), and overall accuracy 94.59% (95% CI 81.81–99.34%), with an area under the ROC curve of 0.986 (95% CI 0.957–1.000). All 11 patients with a pre-operative CSA below 18.5 mm² had an inadequate graft (<8.0 mm); two of the 13 patients with an inadequate graft had CSA ≥18.5 mm² (sensitivity 84.62% for detecting an inadequate graft). Conclusion: Pre-operative ST CSA below 18.5 mm² was associated with an intraoperative graft diameter <8.0 mm in all 11 patients below the threshold, although 2 of 13 undersized grafts were missed. This threshold may serve as a useful pre-operative screening metric to anticipate the need for graft augmentation, pending external validation.